Ultrasound-Guided Erector Spinae Plan Block for Colorectal Surgery

The Comparison of the Erector Spinae Plane Block and Wound Infiltration on Postoperative Opioid Consumption in Patients Undergoing Laparoscopic Colorectal Surgery

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04313764

Enrollment

Registered

2020-03-18

Start date

2020-06-18

Completion date

2020-08-15

Last updated

2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Postoperative Pain

Brief summary

Colorectal cancer is a common and lethal disease. It still remains the third most common cause of cancer death in women and the second leading cause of death in men. Pain control is an important direction of postoperative management in malignancy surgery. Inadequate pain control increases cardiac and respiratory complications in these critical patients. Erector spinae plane (ESP) block is a recently described regional anesthesia technique that blocks the dorsal and ventral rami of the spinal nerves and the sympathetic nerve fibers. While the ESP block has been shown to provide effective postoperative analgesia after thoracic, and abdominal surgeries. Our aim in this study was to investigate bilateral thoracic ESP block for providing successful postoperative pain management following colorectal surgery.

Interventions

DRUGBupivacaine Hcl 0.25% ESP block

Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side

DRUGBupivacaine Hcl 0.25% infiltration

Wound infiltration with 20 ml %0.25 bupivacaine

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* American Society of Anesthesiologist's physiologic state I-II-III patients undergoing Colorectal surgery

Exclusion criteria

* renal or hepatic insufficiency, chronic pain, patients with an allergic reaction to anesthesia and analgesia drugs to be used

Design outcomes

Primary

Measure	Time frame	Description
Opioid Consumption	Postoperative first 24 hours	Opioid consumption postroperative period

Secondary

Measure	Time frame	Description
Visual Analog Pain Score	Postoperative first 24 hours	Pain will be evaluated with a Visual Analogue Scale (VAS) score of 0-10 (0= no pain and 10= worst imaginable pain)

Countries

Turkey (Türkiye)

Contacts

Primary Contactİrem Ates, MD

driremates@hotmail.com00905327401258

Backup ContactAli Ahiskalioglu, MD

aliahiskalioglu@hotmail.com00905444424831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026